These findings underscore the central role of AMPK/SIRT1 signaling in coordinating lipid metabolism and mitochondrial function, offering a promising therapeutic avenue for obesity‐related metabolic disorders through targeted pathway activation. This evidence concerns the gene PRKAA2 and metabolic disease.